DE60232477D1 - Verfahren zur Beseitigung von Viren und Prionen aus Immunglobulinzusammensetzungen - Google Patents

Verfahren zur Beseitigung von Viren und Prionen aus Immunglobulinzusammensetzungen

Info

Publication number
DE60232477D1
DE60232477D1 DE60232477T DE60232477T DE60232477D1 DE 60232477 D1 DE60232477 D1 DE 60232477D1 DE 60232477 T DE60232477 T DE 60232477T DE 60232477 T DE60232477 T DE 60232477T DE 60232477 D1 DE60232477 D1 DE 60232477D1
Authority
DE
Germany
Prior art keywords
prions
immunoglobulin
immunoglobulin compositions
methods
eliminating viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60232477T
Other languages
English (en)
Inventor
Holten Robert Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23074738&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60232477(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of DE60232477D1 publication Critical patent/DE60232477D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60232477T 2001-04-02 2002-04-02 Verfahren zur Beseitigung von Viren und Prionen aus Immunglobulinzusammensetzungen Expired - Lifetime DE60232477D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28080701P 2001-04-02 2001-04-02

Publications (1)

Publication Number Publication Date
DE60232477D1 true DE60232477D1 (de) 2009-07-16

Family

ID=23074738

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60232477T Expired - Lifetime DE60232477D1 (de) 2001-04-02 2002-04-02 Verfahren zur Beseitigung von Viren und Prionen aus Immunglobulinzusammensetzungen

Country Status (7)

Country Link
US (1) US20040110931A1 (de)
EP (1) EP1247818B1 (de)
JP (1) JP4523222B2 (de)
AT (1) ATE432948T1 (de)
AU (1) AU784808B2 (de)
CA (1) CA2379901A1 (de)
DE (1) DE60232477D1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1511391B1 (de) * 2002-05-23 2012-05-02 Ortho-Clinical Diagnostics, Inc. Einfang, konzentration und quantifizierung eines abnormalen prionproteins aus biologischen flüssigkeiten mittels tiefenfiltration
CA2497364C (en) * 2002-09-11 2013-03-19 Chugai Seiyaku Kabushiki Kaisha Protein purification method
EP1614424B1 (de) * 2003-04-09 2015-07-22 The Chemo-Sero-Therapeutic Research Institute Verfahren zur herstellung einer albumin-zubereitung
WO2006042541A1 (en) * 2004-10-21 2006-04-27 Statens Serum Institut A method comprising nanofiltration to obtain an mbl product safe from infectious agents and the product obtainable by this method
PT1809663E (pt) * 2004-11-09 2008-10-02 Ares Trading Sa Um cesto para cultivo de marisco
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
ES2664924T3 (es) 2005-08-26 2018-04-24 Ares Trading S.A. Procedimiento para la preparación del interferón beta glicosilado
AU2006323925B2 (en) 2005-12-09 2012-08-02 Ares Trading S.A. Method for purifying FSH or a FSH mutant
EP1800673A3 (de) * 2005-12-23 2007-08-15 Canadian Blood Services Nitrophenyle und verwandte Zusammensetzungen sowie Thimerosal zur Hemmung von immunspezifischer Zell- oder Gewebezerstörung
AU2010294192A1 (en) 2009-09-10 2012-04-05 Lonza Biologics Plc Method and system for polypeptide purification
WO2015140751A1 (en) * 2014-03-21 2015-09-24 Boreal Invest Terminal nanofiltration of solubilized protein compositions for removal of immunogenic aggregates
IL285529B2 (en) * 2014-05-13 2023-03-01 Amgen Inc Process control systems and methods for the use of filters and filtration processes
CN106950326B (zh) * 2017-03-10 2018-05-29 武汉大学 一种化学标记结合lc-ms的方法及其在核苷酸分析中的应用
CA3098609A1 (en) * 2018-05-17 2019-11-21 Csl Behring Ag Method and system of protein extraction

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
US3449314A (en) * 1966-06-03 1969-06-10 Ortho Pharma Corp Preparation of anti-rh globulin from human plasma
US3916026A (en) * 1968-09-19 1975-10-28 Biotest Serum Institut Gmbh Method for the preparation of gamma-globulin suitable for intravenous use
US4021540A (en) * 1975-07-28 1977-05-03 Ortho Diagnostics Inc. Preparation of a hepatitis B immune globulin and use thereof as a prophylactic material
US4859340A (en) * 1976-03-15 1989-08-22 Cuno, Incorporated Filter sheet
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
US4590002A (en) * 1984-12-10 1986-05-20 Ortho Diagnostic Systems, Inc. Methods for preparation of highly purified, gamma globulins free of hepatitis-B-virus infectivity
US5173415A (en) * 1986-01-20 1992-12-22 Japan Chemical Research Co., Ltd. Process for removal of viruses from solutions of physiologically active substances
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US5115101A (en) * 1988-06-08 1992-05-19 Miles Inc. Removal of protein A from antibody preparations
FR2639645B1 (fr) * 1988-11-25 1992-05-29 Elf Aquitaine Solutions liquides concentrees de polysaccharides
DE4137996A1 (de) * 1991-11-19 1993-05-27 Behringwerke Ag Verfahren zur herstellung eines virussicheren thrombinkonzentrates
US5858641A (en) * 1996-09-17 1999-01-12 Shanbrom Technologies, Llc Disinfectant dye removal from blood and blood fractions using a porous poly(vinyl alcohol-acetal) copolymer
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
FR2772381B1 (fr) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
ES2218118T5 (es) * 1999-01-19 2011-04-06 Common Services Agency Tratamiento de líquidos que contienen proteínas.
US6166187A (en) * 1999-03-05 2000-12-26 The Regents Of The University Of California Method of concentrating prion proteins in blood samples
US6270672B1 (en) * 1999-08-06 2001-08-07 Baxter Aktiengesellschaft Devices and methods for removing pathogens from biological fluids

Also Published As

Publication number Publication date
JP2003064099A (ja) 2003-03-05
JP4523222B2 (ja) 2010-08-11
EP1247818A2 (de) 2002-10-09
EP1247818A3 (de) 2004-03-03
AU784808B2 (en) 2006-06-29
ATE432948T1 (de) 2009-06-15
EP1247818B1 (de) 2009-06-03
US20040110931A1 (en) 2004-06-10
AU2931602A (en) 2002-10-03
CA2379901A1 (en) 2002-10-02

Similar Documents

Publication Publication Date Title
ATE388162T1 (de) Verfahren zur beseitigung von viren
DE60232477D1 (de) Verfahren zur Beseitigung von Viren und Prionen aus Immunglobulinzusammensetzungen
NO20071432L (no) Fremgangsmate for konsentrasjon av antistoffer of terapeutiske produkter derav.
ATE296315T1 (de) Galactosylierte glykoproteine enthaltende zusammensetzungen und verfahren zur deren herstellung
ATE419009T1 (de) Methoden und zusammensetzungen bestehend aus glykoprotein-glykoformen
ATE382358T1 (de) Verfahren und zusammensetzungen zum sauerstofftransport mit hoher sauerstoffaffinität
CY1111232T1 (el) Σκευασματα αντισωματων και πρωτεϊνων υψηλης συγκεντρωσης
DE60210304D1 (de) Verfahren zur herstellung einer proteinhaltigen fraktion, mit beta-tgf in aktivierter form bereichert, sowie die so erhaltene fraktion und deren therapeutische verwendungen
ATE553125T1 (de) Herstellung eines multimeren proteins durch zellfusionsverfahren
DE69432109D1 (de) Synthetische, vielfache tandemwiederholungen des mucinpeptides und seiner derivate und deren verwendung
CY1108571T1 (el) Διεργασια για την παραγωγη και τον καθαρισμο ερυθροποιητινης
ATE346861T1 (de) Verfahren zur reinigung und isolierung von viren, aus pflanzenquellen
ATE258984T1 (de) Bmp-11 zusammensetzungen
DE60027695D1 (de) Verfahren zur herstellung von fibrinogen und fibronectin sowie proteinzusammesetzungen, welche damit herstellbar sind
ATE404588T1 (de) Verfahren zur herstellung von chondroitinsulfaten aus k4-polysaccharid und so hergestellte produkte
SI1511770T1 (sl) Glikoprotein VI-Fc fuzijski protein za zdravljenje vaskularnih bolezni
DE60106469D1 (de) Verfahren zur Herstellung von genetisch veränderten Lymphozyten Vorläuferzellen von Wirbeltieren und deren Gebrauch zur Produktion von heterologen Bindeproteinen
DE69434221D1 (de) Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen
NO20013918L (no) Fremgangsmåte for å inaktivere patogener ved anvendelse av bredspektret pulset lys
ATE328102T1 (de) Verfahren zur herstellung von proteine
ATE212360T1 (de) Polyethylenglycol-hirudin-konjugate, deren verfahren zur herstellung und verwendung für die heilung von thrombosen
ATE506370T1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
ATE169821T1 (de) Verwendung boviner kolostralmilch zur herstellung eines arzneimittels für die behandlung von leberfunktionsstörungen
DE60222405D1 (de) Verfahren zur verbesserung von proteinprodukten
ATE253839T1 (de) Verfahren zur herstellung von molkenproteinaggregaten aus sauermolke

Legal Events

Date Code Title Description
8363 Opposition against the patent